Cluster 509: anti pd antibody pathways targeting specifically ctla checkpoint stimulation cell 
Cluster 1159: pd anti pathway targeting antibody therapeutic agents agonists ctla treatment 
Cluster 2395: ctla therapies targeted pd excluded prior pdl stimulatory targeting checkpoint 
